Initiate the NC762 Phase 1 trial
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- July 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiate the NC762 Phase 1 trial in the second quarter of 2021 and report initial data in mid-2022.”
What we found
Evidence strength A What the grades mean
The 10-K filings state the NC762 Phase 1/2 trial was initiated in July 2021, after the end-of-Q2 2021 deadline. The August 2021 8-K says initiation had occurred but gives no date.
-
A NextCure, Inc. 8-K filed 2021-08-05
“We have initiated clinical development of our third program, NC762 targeting B7-H4, with anticipated initial Phase 1 data mid-2022.” ✓ confirmed on the page
-
A NextCure, Inc. 10-K filed 2022-03-03
“In July 2021, we initiated a Phase 1/2 clinical trial of NC762 in patients with lung cancer, breast cancer, ovarian cancer or potentially other tumor types.” ✓ confirmed on the page
-
A NextCure, Inc. 10-K filed 2022-03-03
“In July 2021, we initiated a Phase 1/2 clinical trial of NC762 in patients with lung cancer, breast cancer, ovarian cancer or potentially other tumor types.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- NC762 Phase 1 trial
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you NextCure, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-NXTC-025101 · Corrections policy